Gene Synthesis Market is estimated to reach US$ 107,797.82 million by 2025 With Eurofins Scientific, Thermo Fisher Scientific Inc., GenScript. Other market players include BIONEER CORPORATION., Integrated DNA Technologies, Inc., ATUM, Twist Bioscience, Bi

According to our new research study on “Gene synthesis in Healthcare Market Forecast to 2025 – COVID-19 Impact and Global Analysis – by Product and Services, Application, and End User,” the market is expected to reach US$ 107,797.82 million by 2025 from US$ 3,991.23 million in 2017; it is estimated to grow at a CAGR of 28.7% from 2017 to 2025. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the Gene synthesis in healthcare market is attributed to the increase in investments & funds for gene synthesis, rising numbers of start-up companies and technological advancements are key drivers for the growth of the market. However, factors such as lack of skilled professionals and long approval processes are likely to restrain the market growth to a certain extent.

(**Note: The sample of this report is updated with COVID-19 impact analysis**)
To Know How COVID-19 Pandemic Will Impact Global Gene Synthesis Market | Get a Sample Copy of Report, Click Here: https://www.theinsightpartners.com/sample/TIPHE100001214/?openpr-10225

The services segment held the major market share among the products & services segments. In 2017, the services segment held a largest market share of 51.1% of the gene synthesis market, by products & services. This segment is also expected to dominate the market in 2025 owing to analysis and data management solutions, service partnerships and financial solutions. Furthermore, the services segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

The Gene synthesis in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Eurofins Scientific, Thermo Fisher Scientific Inc., GenScript. Other market players include BIONEER CORPORATION., Integrated DNA Technologies, Inc., ATUM, Twist Bioscience, BioCat GmbH, OriGene Technologies, Inc. and GENEWIZ. are among the leading companies operating in the Gene synthesis in healthcare market.

The report segments Gene synthesis in healthcare market as follows:

By Products and Services

Software
Consumables
Services

By Application

Research & Development Activities
Diagnostics
Therapeutics
Others

By End User

Academic and Research Institutes
Pharma & Biotech Companies
Diagnostic Laboratories
Others

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Rest of Europe
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of APAC
Middle East & Africa (MEA)
Saudi Arabia
UAE
South Africa
Rest of MEA
South and Central America (SCAM)
Brazil
Argentina
Rest of SCAM

TABLE OF CONTENTS

1. INTRODUCTION 20
2. GLOBAL GENE SYNTHESIS MARKET - KEY TAKEAWAYS 21
3. GLOBAL GENE SYNTHESIS MARKET - MARKET LANDSCAPE 24
4. GLOBAL GENE SYNTHESIS MARKET - KEY MARKET DYNAMICS 37
5. GENE SYNTHESIS MARKET - GLOBAL ANALYSIS 44
6. GENE SYNTHESIS MARKET ANALYSIS- BY PRODUCTS & SERVICES 48
7. GLOBAL GENE SYNTHESIS MARKET ANALYSIS- BY APPLICATION 53
8. GLOBAL GENE SYNTHESIS MARKET ANALYSIS - BY END USER 58
9. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 63
10. EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 74
11. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 85
12. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 95
13. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 105
14. GENE SYNTHESIS MARKET -INDUSTRY LANDSCAPE 111
14.1 OVERVIEW 111
14.2 GROWTH STRATEGIES IN GENE SYNTHESIS MARKET, 2016-2018 111
14.3 ORGANIC GROWTH STRATEGIES 111
14.3.1 Overview 111
14.3.2 Product Launch 112
14.3.3 Expansion 113
14.3.4 Approvals 113
14.4 INORGANIC GROWTH STRATEGIES 114
14.4.1 Overview 114
14.4.2 Agreements 114
14.4.3 Acquisitions 115
14.4.4 Partnerships & Collaborations 116
14.4.5 Other Inorganic Strategies 117
15. GENE SYNTHESIS MARKET -KEY COMPANY PROFILES 118
15.1 THERMO FISHER SCIENTIFIC INC. 118
15.1.1 Key Facts 118
15.1.2 Business Description 118
15.1.3 Financial Overview 119
15.1.4 Product Portfolio 119
15.1.5 SWOT Analysis 120
15.1.6 Key Developments 120
15.2 INTEGRATED DNA TECHNOLOGIES, INC. 121
15.2.1 Key Facts 121
15.2.2 Business Description 121
15.2.3 Financial Overview 121
15.2.4 Product Portfolio 121
15.2.5 SWOT Analysis 122
15.2.6 Key Developments 122
15.3 TWIST BIOSCIENCE 123
15.3.1 Key Facts 123
15.3.2 Business Description 123
15.3.3 Financial Overview 123
15.3.4 Product portfolio 123
15.3.5 SWOT ANALYSIS 124
15.3.6 KEY DEVELOPMENTS 124
15.4 ORIGENE TECHNOLOGIES, INC. 126
15.4.1 Key Facts 126
15.4.2 Business Description 126
15.4.3 Financial Overview 126
15.4.4 Product Portfolio 126
15.4.5 SWOT Analysis 127
15.4.6 Key Developments 127
15.5 BIOCAT GMBH 128
15.5.1 Key Facts 128
15.5.2 Business Description 128
15.5.3 Financial Overview 129
15.5.4 Product Portfolio 129
15.5.5 SWOT Analysis 129
15.5.6 Key Developments 129
15.6 GENSCRIPT 130
15.6.1 Key Facts 130
15.6.2 Business Description 130
15.6.3 Financial Overview 131
15.6.4 Product Portfolio 131
15.6.5 SWOT Analysis 132
15.6.6 Key Developments 132
15.7 EUROFINS SCIENTIFIC 133
15.7.1 Key Facts 133
15.7.2 Business Description 133
15.7.3 Financial Overview 133
15.7.4 Product/ Services Portfolio 134
15.7.5 SWOT Analysis 134
15.7.6 Key Developments 134
15.8 BIONEER CORPORATION 136
15.8.1 Key Facts 136
15.8.2 Business Description 136
15.8.3 Financial Overview 136
15.8.4 Product/ Services Portfolio 137
15.8.5 SWOT Analysis 137
15.8.6 Key Developments 138
15.9 ATUM 139
15.9.1 Key Facts 139
15.9.2 Business Description 139
15.9.3 Financial Overview 140
15.9.4 Product Portfolio 140
15.9.5 SWOT Analysis 140
15.9.6 Key Developments 140
15.10 GENEWIZ 141
15.10.1 Key Facts 141
15.10.2 Business Description 141
15.10.3 Financial Overview 142
15.10.4 Service Portfolio 142
15.10.5 SWOT Analysis 142
15.10.6 Key Developments 143
16. APPENDIX 144

Purchase a copy of the Global Gene Synthesis Market report @ https://www.theinsightpartners.com/buy/TIPHE100001214/?openpr-10225

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.